WILLOW BIOSCIENCES INC (WLLW.CA) Stock Price, Quote, News and Overview
TSX:WLLW - Toronto Stock Exchange - CA97111B4047 - Common Stock - Currency: CAD
WLLW.CA Quote, Performance and Key Statistics
TSX:WLLW (5/21/2025, 7:00:00 PM)
0.04
+0 (+14.29%)
The current stock price of WLLW.CA is 0.04 CAD. In the past month the price increased by 700%. In the past year, price decreased by -52.94%.
WLLW.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 317.40M | ||
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 239.50M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 188.93M | ||
| TH.CA | THERATECHNOLOGIES INC | N/A | 162.77M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 89.95M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 16.35 | 76.23M | ||
| MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 65.22M | ||
| SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 57.70M | ||
| BLU.CA | BLUENERGIES LTD | N/A | 57.06M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 50.37M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | 34 | 47.95M | ||
| ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 46.41M |
Related stock screener links
About WLLW.CA
Company Profile
Willow Biosciences, Inc. is a biotechnology company, which engages in the research, development, and commercialization of plant derived ingredients for consumer care, food and beverage, and pharmaceutical products. The company is headquartered in Calgary, Alberta and currently employs 19 full-time employees. The company went IPO on 2017-09-14. The firm develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. The company also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. The company is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.
Company Info
WILLOW BIOSCIENCES INC
202, 1201 5th Street SW
Calgary ALBERTA T2L 1Y8 CA
CEO: Trevor Peters
Employees: 19
Phone: 14039105140
WILLOW BIOSCIENCES INC / WLLW.CA FAQ
What is the stock price of WILLOW BIOSCIENCES INC today?
The current stock price of WLLW.CA is 0.04 CAD. The price increased by 14.29% in the last trading session.
What is the ticker symbol for WILLOW BIOSCIENCES INC stock?
The exchange symbol of WILLOW BIOSCIENCES INC is WLLW and it is listed on the Toronto Stock Exchange exchange.
On which exchange is WLLW.CA stock listed?
WLLW.CA stock is listed on the Toronto Stock Exchange exchange.
What is WILLOW BIOSCIENCES INC worth?
WILLOW BIOSCIENCES INC (WLLW.CA) has a market capitalization of 5.79M CAD. This makes WLLW.CA a Nano Cap stock.
How many employees does WILLOW BIOSCIENCES INC have?
WILLOW BIOSCIENCES INC (WLLW.CA) currently has 19 employees.
What are the support and resistance levels for WILLOW BIOSCIENCES INC (WLLW.CA) stock?
WILLOW BIOSCIENCES INC (WLLW.CA) has a resistance level at 0.04. Check the full technical report for a detailed analysis of WLLW.CA support and resistance levels.
Should I buy WILLOW BIOSCIENCES INC (WLLW.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of WLLW.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of WLLW.CA, evaluating the profitability, health, valuation and growth aspects
- WILLOW BIOSCIENCES INC (WLLW.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- WILLOW BIOSCIENCES INC (WLLW.CA) Sales and EPS estimates to see what analysts future expectations are.
- WILLOW BIOSCIENCES INC (WLLW.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- WILLOW BIOSCIENCES INC (WLLW.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- WILLOW BIOSCIENCES INC (WLLW.CA) Stock Chart to make your own analysis
- WILLOW BIOSCIENCES INC (WLLW.CA) Latest news and press-releases to stay up to date.
Does WILLOW BIOSCIENCES INC (WLLW.CA) stock pay dividends?
WLLW.CA does not pay a dividend.
When does WILLOW BIOSCIENCES INC (WLLW.CA) report earnings?
WILLOW BIOSCIENCES INC (WLLW.CA) will report earnings on 2025-08-11.
What is the Price/Earnings (PE) ratio of WILLOW BIOSCIENCES INC (WLLW.CA)?
WILLOW BIOSCIENCES INC (WLLW.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.05).
WLLW.CA Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to WLLW.CA. When comparing the yearly performance of all stocks, WLLW.CA is a bad performer in the overall market: 86.67% of all stocks are doing better.
WLLW.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to WLLW.CA. WLLW.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
WLLW.CA Financial Highlights
Over the last trailing twelve months WLLW.CA reported a non-GAAP Earnings per Share(EPS) of -0.05. The EPS increased by 56.89% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -248.65% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
WLLW.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to WLLW.CA. The Buy consensus is the average rating of analysts ratings from 7 analysts.